当前位置: X-MOL 学术Breast Cancer Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis
Breast Cancer Research ( IF 7.4 ) Pub Date : 2020-03-12 , DOI: 10.1186/s13058-020-01265-y
Adi Zundelevich , Maya Dadiani , Smadar Kahana-Edwin , Amit Itay , Tal Sella , Moran Gadot , Karen Cesarkas , Sarit Farage-Barhom , Efrat Glick Saar , Eran Eyal , Nitzan Kol , Anya Pavlovski , Nora Balint-Lahat , Daniela Dick-Necula , Iris Barshack , Bella Kaufman , Einav Nili Gal-Yam

After the publication of the original article [1], we were notified the upper panel of the Fig. 1, where the patients’ codes are listed, was cropped by mistake so the patients 1–8 are repeated.

中文翻译:

校正至:ESR1突变在新诊断为内分泌治疗的乳腺癌的转移和局部复发中很常见,预后更差

原始文章[1]发表后,我们被告知图1的上面板,其中错误列出了患者的代码,因此错误地裁剪了该代码,因此重复了1至8位患者的操作。
更新日期:2020-04-22
down
wechat
bug